Abstract
A major contributor to atypical community-acquired pneumonia, Mycoplasma pneumoniae poses a special challenge in the clinical and scientific arenas because of its unique features, which include its tiny genome size, absence of a cell wall, and capacity to elude host immune responses. The many aspects of Mycoplasma pneumoniae infections, including epidemiology, etiology, clinical symptoms, and diagnostic methods, are thoroughly reviewed in this study. A critical examination of existing treatment techniques and emerging therapeutic options is presented, coupled with an exploration of the changing terrain of antibiotic resistance in strains of Mycoplasma pneumoniae. Comprehensive knowledge of this sneaky pathogen is aided by insights into immune evasion mechanisms, host-pathogen interactions, and the function of Mycoplasma pneumoniae in chronic respiratory infections. This review is a useful resource for physicians, researchers, and other healthcare professionals by combining current scientific findings with clinical viewpoints.
Keywords: Mycoplasma pneumoniae; Respiratory illness; COVID-19; Epidemics